TrialMolecular oncology2015

Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study.

Leonardo Tenori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.